BRISTOL-MYERS SQUIBB COMPANY |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.63 EUR | -0.47% |
|
+1.10% | -18.51% |
| Jul. 11 | Redburn Atlantic Adjusts Price Target on Bristol-Myers Squibb to $50 From $54, Maintains Neutral Rating | MT |
| Jul. 10 | Barclays Adjusts Price Target on Bristol-Myers Squibb to $41 From $43 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Other Pharmaceuticals | +0.04% | +1.10% | -18.51% | -33.43% | - | 82.6B | - | - | - |
